AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
3i Group plc
Video analysis: TGOPF
All videosNo video analysis for this stock yet. Request one from our team.
News: TGOPF
3i Group earns Deutsche Bank price target lift following £660m Action deal
3i Group PLC (LSE:III) successfully increased its core stake in retail business Action following a new share issuance and saw its forecasts updated by Deutsche Bank. The investment firm traded steadily at 2,822p as the broker maintained a 'buy' rating and raised its target price from 3,527p to 3,570p.
3i Group: Why It Stands For Invest, Invest, Invest And Its Flywheel Keeps Turning
3i Group is a world-class compounder, with Action comprising 75% of NAV and driving robust growth. Action's dominant European discount retail model features high margins, rapid payback, and a negative cash conversion cycle, fueling self-sustaining expansion. Current 3i valuation implies a steep discount to Action's peers, despite superior growth, profitability, and cash conversion metrics.
3i Group: Still Not On Board With Action Valuation
3i Group remains unappealing due to the rising cost of capital and lack of catalysts, while asserted multiples don't shrink. TGOPF trades at a 10% discount to asserted NAV, but NAV relies on high, arguably unrealistic, multiple assumptions for the main business, Action. Public comps trade at a fraction of the multiple and have similar growth prospects.
Similar companies
-
Brookfield Asset Management Inc.
BAMGF
·
Other OTC
Compare
-
SCOR Se
SCRYY
·
Other OTC
Compare
-
Crédit Agricole S.A.
CRARY
·
Other OTC
Compare
-
PICC Property and Casualty Company Limited
PPCCY
·
Other OTC
Compare
-
CITIC Securities Company Limited
CIIHF
·
Other OTC
Compare
-
PT Bank Central Asia Tbk
PBCRF
·
Other OTC
Compare